Evidence map›Paper›PMID 40327014›Full record

ArticleJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews2025

Sequential Transcutaneous Mechanical Femoral Lengthening of a Profoundly Short Skeletal Residuum and Subsequent Successful Transfemoral Osseointegration: A Case Report Describing a Novel Endo-Exo Intramedullary Stump Lengthening Device.

Muhammad Taqi, Mustafa Alttahir, Munjed Al Muderis, Kevin Tetsworth, Robert Dettmers

Abstract readCase Reports
In one paragraph

Article in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammad TaqiFrom the Macquarie University Hospital, Macquarie Park, Australia (Dr. Taqi, Dr. Alttahir, and Mr. Al Muderis); Royal Brisbane Hospital, Herston, Australia (Mr. Tetsworth); and the Erasmus MC Rotterdam, Rotterdam, Netherlands (Dr. Dettmers).ORCID 0000-0002-4284-6464
Mustafa Alttahir
Munjed Al Muderis
Kevin Tetsworth
Robert Dettmers

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 17-year-old adolescent girl presented to our specialty referral center to explore the possibility of osseointegration. Diagnosed with right distal femoral Ewing sarcoma at the age of two, she underwent a transfemoral amputation after 6 months of treatment, resulting in an extremely short residual femur of only 21.7 mm below the pyriformis fossa. The primary challenge was to first elongate the short stump to create a sufficient femoral residuum and then successfully perform osseointegration to enable independent mobility. The aim was to regenerate a good length of the bone to support an osseointegration implant to help her walk independently. After rehabilitation, the patient is mobilizing independently and has a level 3 K-value (activity). Her case illustrates the potential of combining advanced three-dimensional modeling and virtual planning, sophisticated design and manufacturing capabilities, and improving surgical techniques to achieve definitive reconstruction of an amputated limb. Such technological advancements promise to expand the possibilities for future innovations in limb reconstruction and patient rehabilitation. The limitation of this femoral residuum lengthening and staged osseointegration is the need for custom implant design and manufacturing, which is patient-specific and requires meticulous planning.

Indexed as

Amputation StumpsBone LengtheningFemoral NeoplasmsFemurOsseointegrationSarcoma, EwingAdolescentAmputation, SurgicalFemaleHumans

Identifiers

PMID40327014
PMCPMC12045531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.